Russian Federation’s updated patent law puts public health first
NewsThe Russian Federation parliament voted this week (13 April 2021) to enshrine into the law the country’s right to enact...
Read more about Russian Federation’s updated patent law puts public health first
Belarus: Civil society pushes for compulsory license as dolutegravir remains overpriced
Call to action NewsPositive Movement (PMPlus) in Belarus, one of our partner organizations, is an NGO representing people living with HIV, advocating for...
Letter to ViiV Healthcare: No more time to waste – increase access to dolutegravir in Eastern Europe and Central Asia
News Press releaseDolutegravir is an essential drug in HIV treatment, recommended by the World Health Organization (WHO). Despite the drug being approved...
Activists urge Eurasian states to order more affordable medicines, after HIV patent is dropped
Call to action NewsAbbVie has waived its patent rights for HIV drug, lopinavir/ritonavir (LPV/r), in many parts of the world, including for the...